113 related articles for article (PubMed ID: 3904231)
1. Eight-year follow-up of adjuvant therapy for stage II breast cancer.
Hubay CA; Gordon NH; Pearson OH; Marshall JS; McGuire WL
World J Surg; 1985 Oct; 9(5):738-49. PubMed ID: 3904231
[No Abstract] [Full Text] [Related]
2. Adjuvant chemotherapy combined with tamoxifen in postmenopausal patients with stage II breast cancer.
Zielinski CC; Kubista E; Salzer H; Sevelda P; Langer M; Staffen A; Spona J; Aiginger P
Lancet; 1986 Nov; 2(8516):1164. PubMed ID: 2877314
[No Abstract] [Full Text] [Related]
3. Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up.
Hubay CA; Gordon NH; Crowe JP; Guyton SP; Pearson OH; Marshall JS; Mansour EG; Hermann RE; Jones JC; Flynn WJ
Surgery; 1984 Jul; 96(1):61-72. PubMed ID: 6740497
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant tamoxifen and chemotherapy in stage II breast cancer: interim findings from NSABP protocol B-09.
Wolmark N; Fisher B
World J Surg; 1985 Oct; 9(5):750-5. PubMed ID: 3904232
[No Abstract] [Full Text] [Related]
5. Adjuvant therapy in primary breast cancer.
Wolmark N; Fisher B
Surg Clin North Am; 1985 Feb; 65(1):161-80. PubMed ID: 3887616
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial.
Tormey C
Recent Results Cancer Res; 1984; 96():155-65. PubMed ID: 6396769
[No Abstract] [Full Text] [Related]
7. Recurrence patterns in a prospective study of patients with stage II breast cancer treated with endocrine-chemotherapy.
Crowe JP; Gordon NH; Antunez AR; Hubay CA; Pearson OH; Marshall JS; McGuire WL
Surgery; 1987 Oct; 102(4):622-7. PubMed ID: 3310297
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy of stage II, III breast cancer.
Buzdar AV; Gutterman JU; Blumenschein GR; Tashima CK; Hortobágyi GN; Yap HY; Hersh EM; Gehan EA
Recent Results Cancer Res; 1978; 68():123-8. PubMed ID: 379930
[No Abstract] [Full Text] [Related]
9. One year of adjuvant tamoxifen compared with chemotherapy and tamoxifen in postmenopausal patients with stage II breast cancer.
Ejlertsen B; Jensen MB; Elversang J; Rasmussen BB; Andersson M; Andersen J; Nielsen DL; Cold S; Mouridsen HT
Eur J Cancer; 2013 Sep; 49(14):2986-94. PubMed ID: 23756360
[TBL] [Abstract][Full Text] [Related]
10. [Adjuvant therapy of breast cancer patients].
Semiglazov VF; Bavli IaL; Moiseenko VM
Vopr Onkol; 1986; 32(11):59-63. PubMed ID: 3097961
[TBL] [Abstract][Full Text] [Related]
11. The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery.
Sorace RA; Bagley CS; Lichter AS; Danforth DN; Wesley MW; Young RC; Lippman ME
World J Surg; 1985 Oct; 9(5):775-85. PubMed ID: 2998103
[No Abstract] [Full Text] [Related]
12. Adjuvant chemotherapy with cyclophosphamide methotrexate and 5-fluorouracil (CMF) in stage II breast cancer in Indian patients.
Shetty PA; Sarda PK; Majumdar AT; Pai VR; Shinde SR; D'Souza LJ; Pinto JM; Jussawalla DJ
Indian J Cancer; 1985 Sep; 22(3):239-44. PubMed ID: 3843327
[No Abstract] [Full Text] [Related]
13. [Polychemotherapy, combined or not to oral BCG, in the treatment of advanced breast cancer: final results of a controlled clinical trial].
Fontes CE; Jaqueto A; da Silva Neto JP; Varella AD; Novo NF
Rev Paul Med; 1987; 105(1):42-6. PubMed ID: 3324269
[No Abstract] [Full Text] [Related]
14. A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB Study.
Wood WC; Weiss RB; Tormey DC; Holland JF; Henry PH; Leone LA; Rafla S; Silver RT; Carey RW; Lesnick GJ
World J Surg; 1985 Oct; 9(5):714-8. PubMed ID: 3840627
[No Abstract] [Full Text] [Related]
15. FAC + BCG as adjuvant therapy in breast cancer: an 8-year update.
Blumenschein GR; Buzdar AU; Hortobagyi GN
Recent Results Cancer Res; 1984; 96():129-32. PubMed ID: 6528087
[No Abstract] [Full Text] [Related]
16. Adjuvant chemotherapy in stage II breast cancer: a brief overview of the NSABP clinical trials.
Wolmark N; Fisher B
World J Surg; 1985 Oct; 9(5):699-706. PubMed ID: 2856855
[No Abstract] [Full Text] [Related]
17. Tamoxifen versus chemotherapy as adjuvant treatment in stage III breast cancer.
Alagaratnam TT; Wong J
Aust N Z J Surg; 1986 Jan; 56(1):39-41. PubMed ID: 3090987
[TBL] [Abstract][Full Text] [Related]
18. Role of adjuvant chemotherapy in male breast cancer.
Patel HZ; Buzdar AU; Hortobagyi GN
Cancer; 1989 Oct; 64(8):1583-5. PubMed ID: 2676137
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
Misset JL; di Palma M; Delgado M; Plagne R; Chollet P; Fumoleau P; Le Mevel B; Belpomme D; Guerrin J; Fargeot P; Metz R; Ithzaki M; Hill C; Mathé G
J Clin Oncol; 1996 Apr; 14(4):1136-45. PubMed ID: 8648368
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
Boccardo F; Rubagotti A; Bruzzi P; Cappellini M; Isola G; Nenci I; Piffanelli A; Scanni A; Sismondi P; Santi L
J Clin Oncol; 1990 Aug; 8(8):1310-20. PubMed ID: 2199618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
